Navigation Links
Spherix Regains Compliance With NASDAQ Listing Rule
Date:5/24/2011

maceuticals, medical devices, consumer products and industrial chemicals and pesticides.  For more information, please visit www.spherix.com.

Forward-Looking Statements

This release contains forward-looking statements which are made pursuant to provisions of Section 21E of the Securities Exchange Act of 1934. Investors are cautioned that such statements in this release, including statements relating to planned clinical study design, regulatory and business strategies, plans and objectives of management and growth opportunities for existing or proposed products, constitute forward-looking statements which involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the forward-looking statements. The risks and uncertainties include, without limitation, risks that product candidates may fail in the clinic or may not be successfully marketed or manufactured, we may lack financial resources to complete development of D-tagatose, the FDA may interpret the results of studies differently than us, competing products may be more successful, demand for new pharmaceutical products may decrease, the biopharmaceutical industry may experience negative market trends, our continuing efforts to develop D-tagatose may be unsuccessful, our common stock could be delisted from the Nasdaq Capital Market, and other risks and challenges detailed in our filings with the U.S. Securities and Exchange Commission, including our current report on Form 8-K filed on October 10, 2007. Readers are cautioned not to place undue reliance on any forward-looking statements which speak only as of the date of this release. We undertake no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances that occur after the date of this release or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Spherix Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spherix Announces First Quarter Financial Results
2. Spherix Announces Reverse Stock Split Effective May 6, 2011
3. Spherix to Effect Reverse Stock Split
4. Spherix Announces 2010 Financial Results
5. Spherix to Present at the BIO-Windhover/Pharmaceutical Strategic Outlook 2011 Conference
6. Spherix to Present at the 13th Annual BIO CEO & Investor Conference
7. Spherix Announces Closing of Registered Direct Offering of $2.77 Million in Common Stock and Warrants
8. Spherix to Present at Two Upcoming Prominent Finance Conferences
9. Spherix Phase 2 Trial with D-tagatose Determines Minimum Dose for HbA1c and Triglycerides
10. Spherix Signs Research Contract With a Leading Global Contract Research Organization to Investigate Role of D-tagatose in Lowering Triglycerides
11. Spherix to Hold Business Update Conference Call December 9, 2010 at 4:30 p.m. Eastern Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 19, 2014 Naurex Inc., a biopharmaceutical ... for diseases of the central nervous system, today announced ... executive officer, will present at the 33 rd ... take place at 3:00 p.m. PST on Tuesday, January ... San Francisco, Calif. ...
(Date:12/19/2014)... -- Decision Resources Group finds that the Latin American ... compound annual growth rate through 2023. This is primarily ... increasing adoption of dental implants. Growing aesthetic consciousness in ... demand for dental biomaterials because they can improve the ... Other key findings from Decision Resources Group,s coverage ...
(Date:12/19/2014)... Today, TiFiber, Inc. announced ... and future company headquarters in Fort Smith, Arkansas ... that safely and effectively control dangerous microorganisms. Fort ... historic, strong support for manufacturing, but also due ... technology-based companies such as TiFiber. , In ...
(Date:12/19/2014)... Reports from CDC show approximately 117 ... or more chronic health conditions - including cardiovascular disease, ... of these diseases, but may not eliminate the severe ... implanted nerve stimulation devices today offer relief, they require ... induce side effects. , To eliminate the need ...
Breaking Biology Technology:Naurex to Present at 33rd Annual J.P. Morgan Healthcare Conference 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 2Latin American Dental Biomaterial Market Will Expand at a 12 Percent Annual Growth Rate Through 2023 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 2Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 3Technology Company TiFiber™ to Establish Production Facility in Fort Smith, Arkansas with Support from Local Investors 4Draper Wins GSK Funding for Smaller, Smarter Implantable Devices 2
... MNKD ) announced today that it has agreed to ... in registered direct offerings to,Alfred E. Mann, its principal ... Directors, and to two groups of investors,including accounts managed ... 15,940,489 shares were sold to Mr. Mann at a ...
... Reba McEntire, NFL Players Among Stars Participating in, PSA Campaign Created ... Renowned Photographer Mary Ellen Mark and Cancer Vixen ... Author Marisa Acocella Marchetto, Partnership with ... of Life & Dating, Starring Ricki Lake and Holly Robinson, Peete, ...
... Oct. 2 /PRNewswire-FirstCall/ - Vasogen Inc.,(NASDAQ: VSGN ; ... and,commercial development of technologies targeting the chronic inflammation,underlying ... after the close of the North American financial ... and audio web cast will also,be conducted on ...
Cached Biology Technology:MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock 2MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock 3Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Television's 13th Annual Multi-Platform 'Stop Breast Cancer For Life' Campaign 2Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Television's 13th Annual Multi-Platform 'Stop Breast Cancer For Life' Campaign 3Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Television's 13th Annual Multi-Platform 'Stop Breast Cancer For Life' Campaign 4Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Television's 13th Annual Multi-Platform 'Stop Breast Cancer For Life' Campaign 5Celebrities and Notables From the Worlds of Film, Television, Music and Sports Join Lifetime Television's 13th Annual Multi-Platform 'Stop Breast Cancer For Life' Campaign 6Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation 2Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation 3Vasogen Announces Third Quarter Conference Call and Webcast of Bio InvestorForum 2007 Presentation 4
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "Global Facial Recognition Market 2015-2019" ... http://photos.prnewswire.com/prnh/20130307/600769 Facial recognition ... individuals. Facial recognition system measures the overall facial ... edges, mouth, and the distance between eyes. Facial ...
(Date:12/11/2014)...  That blood pressure plays a role in human health ... medical term for high blood pressure – was first described ... cuff that,s used in measuring blood pressure was invented in ... about hypertension, its triggers and its effects. In fact, recent ... the best ways to treat it. For example, ...
(Date:12/10/2014)... 9, 2014  Valencell, a leader in performance biometric ... staggering demand from its licensees for highly accurate, clinically ... not solely coming from fitness and health sectors, but ... "A wearable is only as useful as the biometric ... ultimate driver in long-term mass consumer adoption of wearable ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... The human genome has been decoded. Of all the puzzles ... genome provides the blueprint for various proteins, the building blocks ... play? Which proteins control cell division in a healthy body, ... which cells incessantly subdivide and control over proteins gets out ...
... genes in the human genome is what makes each human ... researchers at the Johns Hopkins Bloomberg School of Public Health, ... of Mental Health found that many gene expression changes that ... of fetal expression changes are also seen again much later ...
... German . The ability to dream is ... and emotions that we experience so intensively when we dream form ... not been possible to measure dream content. Max Planck scientists working ... for the first time, in analysing the activity of the brain ...
Cached Biology News:Cell cultures from a machine 2Scientists chart gene expression in the brain across lifespan 2Scientists measure dream content for the first time 2
... of gene expression) technology allows ... profiles generated by SAGE are ... transcripts making it possible to ... Kit is designed to make ...
Sheep Serum US Origin...
... For the ultimate in utility and ... to meet the needs of the researcher. ... interior dimensions or as sheet material that ... enclosures. These isolators are autoclavable and non-cytotoxic ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
Biology Products: